⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety Study of A-101 Topical Solution for the Treatment of Common Warts

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Official Title: A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Study ID: NCT03812510

Conditions

Common Wart

Interventions

A-101

Study Description

Brief Summary: A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Detailed Description: A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Keywords

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Aclaris Investigational Site, Mobile, Alabama, United States

Aclaris Investigational Site, Glendale, Arizona, United States

Aclaris Investigational Site, Fort Smith, Arkansas, United States

Aclaris Investigational Site, Hot Springs, Arkansas, United States

Aclaris Investigational Site, Encinitas, California, United States

Aclaris Investigational Site, Fountain Valley, California, United States

Aclaris Investigational Site, San Diego, California, United States

Aclaris Investigational Site, San Diego, California, United States

Aclaris Investigational Site, Denver, Colorado, United States

Aclaris Investigational Site, Aventura, Florida, United States

Aclaris Investigational Site, Jacksonville, Florida, United States

Aclaris Investigational Site, Miami, Florida, United States

Aclaris Investigational Site, Miami, Florida, United States

Aclaris Investigational Site, Ocala, Florida, United States

Aclaris Investigational Site, Newnan, Georgia, United States

Aclaris Investigational Site, Indianapolis, Indiana, United States

Aclaris Investigational Site, New Albany, Indiana, United States

Aclaris Investigational Site, Louisville, Kentucky, United States

Aclaris Investigational Site, Rockville, Maryland, United States

Aclaris Investigational Site, Fridley, Minnesota, United States

Aclaris Investigational Site, Saint Joseph, Missouri, United States

Aclaris Investigational Sites, Omaha, Nebraska, United States

Aclaris Investigational Site, Las Vegas, Nevada, United States

Aclaris Investigational Site, Verona, New Jersey, United States

Aclaris Investigational Site, Rochester, New York, United States

Aclaris Investigational Site, Raleigh, North Carolina, United States

Aclaris Investigational Site, Beachwood, Ohio, United States

Aclaris Investigational Site, Bexley, Ohio, United States

Aclaris Invesgational Site, Broomall, Pennsylvania, United States

Aclaris Investigational Site, Fort Washington, Pennsylvania, United States

Aclaris Investigational Site, Upper Saint Clair, Pennsylvania, United States

Aclaris Investigational Site, Anderson, South Carolina, United States

Aclaris Investigational Site, Charleston, South Carolina, United States

Aclaris Investigational Site, Fountain Inn, South Carolina, United States

Aclaris Investigational Site, Knoxville, Tennessee, United States

Aclaris Investigational Site, Nashville, Tennessee, United States

Aclaris Investigational Site, Arlington, Texas, United States

Aclaris Investigational Site, Austin, Texas, United States

Aclaris Investigational Site, College Station, Texas, United States

Aclaris Investigational Site, Houston, Texas, United States

Aclaris Investigational Site, Pflugerville, Texas, United States

Aclaris Investigational Site, San Antonio, Texas, United States

Aclaris Investigational Site, Lynchburg, Virginia, United States

Aclaris Investigational Site, Norfolk, Virginia, United States

Aclaris Investigational Site, Norfolk, Virginia, United States

Aclaris Investigational Site, Spokane, Washington, United States

Contact Details

Name: David Gordon, MB, ChB

Affiliation: Aclaris Therapeutics

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: